. Show Affiliations »
Abstract
Entities: Gene
Mesh: See more » Anti-HIV Agents/administration & dosageAnti-HIV Agents/economicsCapital FinancingDisease Transmission, Infectious/prevention & controlEmtricitabine/administration & dosageEmtricitabine/economicsEnglandHIV Infections/prevention & controlHealth PolicyHumansPre-Exposure Prophylaxis/economicsPre-Exposure Prophylaxis/methodsTenofovir/administration & dosageTenofovir/economics
Substances: See more » Anti-HIV AgentsTenofovirEmtricitabine
Year: 2017 PMID: 28007341 DOI: 10.1016/S2352-3018(16)30230-2
Source DB: PubMed Journal: Lancet HIV ISSN: 2352-3018 Impact factor: 12.767